Deep, repeatable capability across the indications that matter most to our sponsors and our community.
Inflammatory and immune-mediated disease, from early signal to confirmatory work.
Cardiometabolic and weight-management programs, including incretin therapeutics.
Prophylactic and seasonal vaccine trials with rapid, diverse enrollment.
Diabetes, lipids, and cardiovascular risk across connected indications.
From UTI and RSV to COVID and influenza — prevention and treatment programs.
Respiratory and airway studies, with onsite spirometry and diagnostics.
Sleep-disorder research with overnight capability and monitored assessments.
Phase I and early-phase studies in generally healthy adults.
From a single specimen to a sponsor's live dashboard — every step is instrumented, documented, and visible.
A diverse database, relentless retention, same-day data, and compliant systems — the operational edge that de-risks your timeline.
Contract to site activation in as few as 1–28 days.
From site-initiation visit to first patient in — often within 24 hours.
Source data entered the day it's captured, by a dedicated team.
Data queries resolved within 24 hours.
eSource & eRegulatory on validated, compliant systems.
Compensation and study-related care at no cost to qualified participants. Conditions shown are de-identified and IRB-reviewed.
Physicians, coordinators, and data specialists who treat every participant as a person and every dataset as a promise.
Meet the full team →A Phase I unit, full procedure suite, CLIA lab, and complete imaging — each capability as a living motion study.
Explore capabilities →A top-3 enroller on most studies, routinely 150–200% of target — with zero findings across multiple FDA inspections.
View track record →Modesto, Manteca, San Carlos, Sugar Land, and Princeton — coast to coast.